Filing Details
- Accession Number:
- 0001192482-18-000474
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-13 16:17:41
- Reporting Period:
- 2018-11-07
- Accepted Time:
- 2018-11-13 16:17:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1138776 | Aevi Genomic Medicine Inc. | GNMX | Biological Products, (No Disgnostic Substances) (2836) | 980217544 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1304755 | Jr J Joseph Grano | C/O Aevi Genomic Medicine, Inc. 435 Devon Park Drive, Suite 715 Wayne PA 19087 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-11-07 | 26,000 | $1.16 | 75,683 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-11-07 | 21,000 | $1.17 | 27,000 | No | 4 | P | Indirect | By wife |
Common Stock | Acquisiton | 2018-11-07 | 21,000 | $1.15 | 56,780 | No | 4 | P | Indirect | By The Grano Children's Trust Robert Silver and Joseph C Grano Trustees |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Indirect | By wife |
No | 4 | P | Indirect | By The Grano Children's Trust Robert Silver and Joseph C Grano Trustees |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 15,384 | Indirect | By The Grano Family Foundation |
Footnotes
- The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions ranging from $1.15 to $1.17, inclusive. The reporting person undertakes to provide to the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- Total amount revised to reflect 7,000 shares of common stock incorrectly reported as owned by the reporting person.
- Includes 6,000 shares of common stock previously reported as held directly by the reporting person.
- Includes 35,780 shares of common stock previously reported as held directly by the reporting person.